{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:59:20Z","timestamp":1740135560447,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ferring Pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Nocturia is one of the most bothersome lower urinary tract symptoms and often impairs sleep quality in the elderly. Although previous studies on nocturia have indicated that the successful treatment of nocturia improves sleep quality, most used questionnaires and activity devices to analyze sleep\/wake patterns. Therefore, there is little information about the treatment effects of desmopressin on objective sleep quality. The aim of the DISTINCT study is to investigate the change in subjective and objective sleep quality using electroencephalography (EEG) and the Pittsburgh Sleep Quality Index (PSQI) after the administration of desmopressin in patients with nocturia due to nocturnal polyuria.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A total of 20 male patients, \u226565\u2009years old, with nocturnal polyuria, defined as a nocturnal polyuria index (NPi) (nocturnal urine volume \/ 24\u2009h urine volume) value \u22650.33, will participate in this study. The participants must have a nocturnal frequency of \u22652 and the first uninterrupted sleep period (FUSP) must occur within &lt;\u20092.5\u2009h. Desmopressin 50\u2009\u03bcg per day will be orally administered before going to bed for 4\u2009weeks. Urinary frequency volume charts (FVC) and EEG will be recorded prior to treatment and at 1\u2009week and 4\u2009weeks after the initiation of treatment. The PSQI will be completed before and 4\u2009weeks after treatment. The primary endpoint is the change from baseline in the mean time of slow-wave sleep (sleep stages N3 and N4) at 4\u2009weeks. The secondary endpoints include the change in the mean value of each sleep variable, the mean delta power during the FUSP, the correlation between nocturnal urinary frequency and slow-wave sleep time, and the change in PSQI score before and after treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>The DISTINCT study will provide valuable evidence to indicate that oral desmopressin treatment for nocturnal polyuria prolongs the FUSP, resulting in the extension of slow-wave sleep time associated with sleep quality.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>The Japan Registry of Clinical Trials (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCTs051190080\">jRCTs051190080<\/jats:ext-link>). Registered 9 December, 2019.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12894-020-00668-5","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T05:02:48Z","timestamp":1594443768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2870-0466","authenticated-orcid":false,"given":"Kazumasa","family":"Torimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makito","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,11]]},"reference":[{"key":"668_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jpsychores.2004.04.003","volume":"56","author":"R Asplund","year":"2004","unstructured":"Asplund R. Nocturia, nocturnal polyuria, and sleep quality in the elderly. J Psychosom Res. 2004;56:517\u201325.","journal-title":"J Psychosom Res"},{"key":"668_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/nau.23917","volume":"38","author":"H Hashim","year":"2019","unstructured":"Hashim H, Blanker MH, Drake MJ, Djurhuus JC, Meijlink J, Morris V, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019;38:179\u201383.","journal-title":"Neurourol Urodyn"},{"key":"668_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.juro.2012.09.118","volume":"189","author":"A Hirayama","year":"2013","unstructured":"Hirayama A, Torimoto K, Mastusita C, Okamoto N, Morikawa M, Tanaka N, et al. Evaluation of factors influencing the natural history of nocturia in elderly subjects: results of the Fujiwara-kyo study. J Urol. 2013;189:980\u20136.","journal-title":"J Urol"},{"key":"668_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1464-410X.2006.06390.x","volume":"98","author":"MH Bing","year":"2006","unstructured":"Bing MH, Moller LA, Jennum P, Mortensen S, Skovgaard LT, Lose G. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int. 2006;98:599\u2013604.","journal-title":"BJU Int"},{"key":"668_CR5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1464-410X.2003.04527.x","volume":"92","author":"KS Coyne","year":"2003","unstructured":"Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int. 2003;92:948\u201354.","journal-title":"BJU Int"},{"key":"668_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1442-2042.2011.02956.x","volume":"19","author":"K Yoshimura","year":"2012","unstructured":"Yoshimura K. Correlates for nocturia: a review of epidemiological studies. Int J Urol. 2012;19:317\u201329.","journal-title":"Int J Urol"},{"key":"668_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.sleep.2008.04.002","volume":"10","author":"DL Bliwise","year":"2009","unstructured":"Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2009;10:540\u20138.","journal-title":"Sleep Med"},{"key":"668_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.sleep.2014.05.013","volume":"15","author":"DL Bliwise","year":"2014","unstructured":"Bliwise DL, Holm-Larsen T, Goble S. Increases in duration of first uninterrupted sleep period are associated with improvements in PSQI-measured sleep quality. Sleep Med. 2014;15:1276\u20138.","journal-title":"Sleep Med"},{"key":"668_CR9","first-page":"17","volume":"Suppl 4","author":"N Stanley","year":"2005","unstructured":"Stanley N. The underestimated impact of nocturia on quality of life. Eur Urol. 2005;Suppl 4:17\u20139.","journal-title":"Eur Urol"},{"key":"668_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.juro.2012.12.112","volume":"190","author":"JP Weiss","year":"2013","unstructured":"Weiss JP, Herschorn S, Albei CD, van der Meulen EA. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013;190:965\u201372.","journal-title":"J Urol"},{"key":"668_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.eururo.2007.01.027","volume":"52","author":"P Kerrebroeck","year":"2007","unstructured":"Kerrebroeck P, Rezapour M, Cortesse A, Th\u00fcroff J, Riis A, N\u00f8rgaard JP. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol. 2007;52:221\u20139.","journal-title":"Eur Urol"},{"key":"668_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s41105-016-0078-2","volume":"15","author":"S Nonoue","year":"2017","unstructured":"Nonoue S, Mashita M, Haraki S, Mikami A, Adachi H, Yatani H, et al. Inter-scorer reliability of sleep assessment using EEG and EOG recording system in comparison to polysomnography. Sleep Biol Rhythms. 2017;15:39\u201348.","journal-title":"Sleep Biol Rhythms"},{"key":"668_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/nau.22724","volume":"34","author":"D Bliwise","year":"2015","unstructured":"Bliwise D, Dijk DJ, Juul KV. Nocturia is associated with loss of deep sleep independently from sleep apnea. Neurourol Urodyn. 2015;34:392.","journal-title":"Neurourol Urodyn"},{"key":"668_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.juro.2016.07.088","volume":"197","author":"C Matsushita","year":"2017","unstructured":"Matsushita C, Torimoto K, Goto D, Morizawa Y, Kiba K, Shinohara M, et al. Linkage of lower urinary tract symptoms to sleep quality in elderly men with nocturia: a community based study using home measured electroencephalogram data. J Urol. 2017;197:204\u20139.","journal-title":"J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-020-00668-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T23:17:44Z","timestamp":1625959064000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00668-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00668-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"type":"electronic","value":"1471-2490"}],"subject":[],"published":{"date-parts":[[2020,7,11]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In accordance with the law for clinical research in Japan, the protocol of this study was approved by the Nara Medical University Certified Review Board (Approval Number; nara0012). This study is conducted in compliance with the articles of the Declaration of Helsinki (revised in October 2013) and in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects established by the Ministry of Health, Labor, and Welfare in Japan. This study is also conducted in accordance with the law for clinical research in Japan (the Clinical Trials Act). In accordance with the Japanese Clinical Trials Act, this study is also registered in the Japan Registry of Clinical Trials (jRCTs051190080). The principal investigator or co-investigator will provide an explanation regarding the study to each eligible participant, using informed consent documents approved by the review board. Participants who give written informed consent will be registered in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All named authors take responsibility for the integrity of the work as a whole and have given their approval for this paper to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The funding of this protocol by the manufacturer of desmopressin is a competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}